Lipoprotein (a) levels in end-stage renal failure and renal transplantation.

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Nephron

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1159/000187400PMID 8366981
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Serum lipids and lipoproteins during continuous ambulatory peritoneal dialysis.

  2009cited by this paper
• A NEW SERUM TYPE SYSTEM IN MAN--THE LP SYSTEM.

  2009cited by this paper
• Immunochemical quantification of human plasma Lp(a) lipoprotein

  2006cited by this paper
• Genetics of the quantitative Lp(a) lipoprotein trait

  2004cited by this paper
• Increased serum apolipoprotein(a) in patients with chronic renal failure treated with continuous ambulatory peritoneal dialysis.

  1992cited by this paper
• Increased lipoprotein (a) levels in subjects with chronic renal failure on hemodialysis.

  1992cited by this paper
• Effect of simvastatin treatment on the dyslipoproteinemia in CAPD patients.

  1991cited by this paper
• Lipoprotein-apolipoprotein changes in renal transplant recipients: a 2-year follow-up.

  1991cited by this paper
• Follow-up of lipid and apoprotein levels in renal transplant recipients.

  1991cited by this paper
• Lovastatin treatment of hypercholesterolemia in renal transplant recipients.

  1990cited by this paper
• Abnormalities of lipoprotein metabolism in patients with the nephrotic syndrome.

  1990cited by this paper
• Lipoprotein(a) is an independent risk factor for myocardial infarction at a young age.

  1990cited by this paper
• Pathogenesis of hyperlipidemia in the nephrotic syndrome.

  1990cited by this paper
• Kinetics of peritoneal protein loss during CAPD: II. Lipoprotein leakage and its impact on plasma lipid levels.

  1990cited by this paper
• The effect of the American Heart Association step one diet on hyperlipidemia following renal transplantation.

  1990cited by this paper
• Relation of serum lipoprotein(a) concentration and apolipoprotein(a) phenotype to coronary heart disease in patients with familial hypercholesterolemia.

  1990cited by this paper
• Gemfibrozil improves abnormalities of lipid metabolism in patients on continuous ambulatory peritoneal dialysis: the role of postheparin lipases in the metabolism of high-density lipoprotein subfractions.

  1989cited by this paper
• HMG CoA reductase inhibitors lower LDL cholesterol without reducing Lp(a) levels.

  1989cited by this paper
• Lipids, lipoproteins and apolipoproteins A-I and B and apolipoprotein losses in continuous ambulatory peritoneal dialysis.

  1989cited by this paper
• Lipoprotein and apolipoprotein losses during continuous ambulatory peritoneal dialysis.

  1989cited by this paper
• Lp(a) lipoprotein concentration in serum of patients with heavy proteinuria of different origin.

  1989cited by this paper
• Serum apolipoprotein profile of hypertriglyceridemic patients with chronic renal failure on hemodialysis: a comparison with type IV hyperlipoproteinemic patients.

  1989cited by this paper
• Lipoproteins and apolipoproteins during the progression of chronic renal disease.

  1988cited by this paper
• Lipoprotein Lp(a): A Risk Factor for Myocardial Infarction

  1988cited by this paper
• Lipoprotein lipid abnormalities in healthy renal transplant recipients: persistence of low HDL2 cholesterol.

  1987cited by this paper
• Lp(a) lipoprotein in patients with chronic renal failure treated by hemodialysis.

  1987cited by this paper
• Hyperapobetalipoproteinemia: the major dyslipoproteinemia in patients with chronic renal failure treated with chronic ambulatory peritoneal dialysis.

  1987cited by this paper
• Plasma cholesterol metabolism in end-stage renal disease. Difference between treatment by hemodialysis or peritoneal dialysis.

  1986cited by this paper
• Lp(a) lipoprotein as a risk factor for myocardial infarction.

  1986cited by this paper
• Lp(a) lipoprotein as a risk factor for coronary heart disease and cerebral infarction.

  1986cited by this paper
• Sequential changes in serum lipids and their subfractions in patients receiving continuous ambulatory peritoneal dialysis.

  1983cited by this paper
• Analysis of cardiovascular risk factors in chronic hemodialysis patients with special attention to the hyperlipoproteinemias.

  1983cited by this paper
• Increased lipoprotein-remnant formation in chronic renal failure.

  1982cited by this paper
• Diverging effects of cholestyramine on apolipoprotein B and lipoprotein Lp(a). A dose-response study of the effects of cholestyramine in hypercholesterolaemia.

  1982cited by this paper
• Lipid abnormalities in uremia, dialysis, and transplantation.

  1981cited by this paper
• The role of multiple pharmaco-therapy in the pathogenesis of hyperlipidemia after renal transplantation.

  1981cited by this paper
• Standardization of immunochemical quantitation of human apolipoproteins A and B

  1980cited by this paper
• Ischemic heart disease in patients with uremia undergoing maintenance hemodialysis.

  1979cited by this paper
• Plasma high-density lipoprotein concentrations in chronic-hemodialysis and renal-transplant patients.

  1977cited by this paper
• Radioimmunoassay of human plasma Lp(a) lipoprotein.

  1977cited by this paper
• Defective triglyceride removal in lipemia associated with peritoneal dialysis and haemodialysis.

  1976cited by this paper
• Accelerated atherosclerosis in prolonged maintenance hemodialysis.

  1974cited by this paper
• Hypertriglyceridemia. A metabolic consequence of chronic renal failure.

  1968cited by this paper

• Apolipoproteins in Chronic Kidney Disease and Kidney Transplant: A Long Unfinished Story

  2025cites this paper
• A retrospective study of lipid profile during the various phases of timing in renal failure and hypothyroid patients

  2023cites this paper
• Non-genetic influences on lipoprotein(a) concentrations

  2022cites this paper
• Severe hypertriglyceridemia in an infant on chronic hemodialysis

  2022cites this paper
• Lipoprotein Abnormalities in Chronic Kidney Disease and Renal Transplantation

  2021influential citation
• Lipoprotein(a) and kidney diseases

  2021cites this paper
• CARDIAC DISEASE IN RENAL FAILURE

  2020cites this paper
• Lipoprotein(a)

  2019cites this paper
• A study on lipoprotein(a) in health and type-2 diabetes mellitus

  2017cites this paper
• Lipoprotein (a) Management: Lifestyle and Hormones.

  2017cites this paper
• Lipoprotein (a): impact by ethnicity and environmental and medical conditions

  2016cites this paper
• Heparin induces an accumulation of atherogenic lipoproteins during hemodialysis in normolipidemic end‐stage renal disease patients

  2015cites this paper
• Definition of postprandial lipaemia.

  2011cites this paper
• Effect of over-the-counter fish-oil administration on plasma Lp(a) levels in an end-stage renal disease population.

  2009cites this paper
• Effects of Renal Replacement Therapy on Plasma Lipoprotein(a) Levels

  2007cites this paper
• Dyslipidaemia and hyperlipidaemia following renal transplantation

  2006cites this paper
• Apolipoprotein E gene polymorphism in renal transplant recipients: effects on lipid metabolism, atherosclerosis and allograft function

  2004cites this paper
• UNIVERSIDADE FEDERAL DO RIO GRANDE DO SUL FACULDADE DE CIÊNCIAS MÉDICAS PROGRAMA DE PÓS-GRADUAÇÃO EM CIÊNCIAS MÉDICAS: NEFROLOGIA

  2003cites this paper
• Lipoprotein (a) in Chronic Renal Failure: Effect of Maintenance Hemodialysis

  2003cites this paper
• Prediction of Relapse by Plasma Lipoprotein(a) Concentration in Children with Steroid-Sensitive Nephrotic Syndrome

  2002cites this paper
• Association of kidney function with serum lipoprotein(a) level: the third National Health and Nutrition Examination Survey (1991-1994).

  2002cites this paper
• Serum Lipoprotein (a) Levels in Chronic Renal Failure and Liver Cirrhosis Patients. Relationship with Atherosclerosis

  2002cites this paper
• Lipoprotein(A) in renal transplant recipients.

  2002cites this paper
• MANAGEMENT OF SELECTED LIPID ABNORMALITIES

  2001cites this paper
• Prevalence of biliary lithiasis in a Sicilian population of hemodialysis patients.

  2001cites this paper
• Effect of apolipoprotein E polymorphism on serum lipid, lipoproteins, and atherosclerosis in hemodialysis patients.

  2000cites this paper
• Management of selected lipid abnormalities. Hypertriglyceridemia, low HDL cholesterol, lipoprotein(a), in thyroid and renal diseases, and post-transplantation.

  2000cites this paper
• Pentanucleotide Repeat and Size Polymorphisms in the Apolipoprotein(a) Gene Are Associated with the Lipoprotein(a) Concentration in Chronic Hemodialysis Patients

  1999cites this paper
• Lipoprotein(a) plasma concentrations after renal transplantation: a prospective evaluation after 4 years of follow-up.

  1999cites this paper
• Lipoprotein(a) levels in relation to albumin concentration in childhood nephrotic syndrome.

  1999cites this paper
• Carotid atherosclerosis in renal transplant recipients: relationships with cardiovascular risk factors and plasma lipoproteins.

  1999cites this paper
• Effects of Mediterranean Diet on Lipid Levels and Cardiovascular Risk in Renal Transplant Recipients

  1999cites this paper
• Lipid abnormalities in end stage renal disease.

  1998cites this paper
• [Lipoprotein(a) and lipids in chronic renal insufficiency and kidney transplant].

  1998cites this paper
• Influence of hematocrit on the measurement of lipoproteins demonstrated by the example of lipoprotein(a).

  1998cites this paper
• [Cardiac pathology of extracardiac origin (IX)> Cardiac pathology in the patient with chronic nephropathy].

  1998cites this paper
• Atherothrombogenicity of lipoprotein(a): the debate.

  1998cites this paper
• Patología cardíaca en el paciente con nefropatía crónica

  1998cites this paper
• Early elevation of lipoprotein(a) levels in chronic renal insufficiency.

  1997cites this paper
• Effects of cyclosporin A and FK 506 on lipid metabolism and fibrinogen in kidney transplant recipients

  1997cites this paper
• Derangement of lipid metabolism and its management in renal transplant patients.

  1997cites this paper
• Anticardiolipin antibodies and lipoprotein (a) levels in patients with chronic renal failure treated with dialysis: associations with atherothrombotic disease.

  1996cites this paper
• Lipoprotein metabolism in renal replacement therapy: a review.

  1996cites this paper
• Post-transplant hyperlipidemia: mechanisms and management.

  1996cites this paper
• [Coronary risk factors in chronic hemodialysis patients].

  1996cites this paper
• HDL subfractions distribution in renal transplant recipients: lack of evidence of a reduction of HDL2 particles.

  1996cites this paper
• Increased plasma lipoprotein(a) in continuous ambulatory peritoneal dialysis is related to peritoneal transport of proteins and glucose.

  1996cites this paper
• Omega-3 fatty acid supplementation and lipoprotein(a) concentrations in patients with chronic glomerular diseases.

  1996cites this paper
• Lipoprotein(a) in chronic renal disease.

  1996cites this paper
• Lipoprotein(a) in renal disease.

  1996cites this paper
• Lipoprotein(a) in health and disease.

  1996cites this paper
• Lipoprotein (a) Levels in Patients Undergoing Continuous Ambulatory Peritoneal Dialysis

  1996cites this paper
• Lipid Parameters Including Lipoprotein (A) in Patients Undergoing CAPD and Hemodialysis

  1995cites this paper
• Lipoprotein(a) levels in patients receiving renal replacement therapy: methodologic issues and clinical implications.

  1995cites this paper
• Multicenter study of lipoprotein(a) and apolipoprotein(a) phenotypes in patients with end-stage renal disease treated by hemodialysis or continuous ambulatory peritoneal dialysis.

  1995cites this paper
• Abnormal lipoprotein (a) and lipid profiles in renal allograft recipients: effects of treatment with pravastatin.

  1995cites this paper
• Levels of Lipoprotein(a), Apolipoprotein B, and Lipoprotein Cholesterol Distribution in IDDM: Results From Follow-Up in the Diabetes Control and Complications Trial

  1995cites this paper
• Cardiac disease in patients with end-stage renal disease.

  1995cites this paper
• Comparison of Lp(a) concentrations and some potential effects in hemodialysis, CAPD, transplantation, and control groups, and review of the literature.

  1995cites this paper
• Effect of fluvastatin on lipoprotein profiles in treating renal transplant recipients with dyslipoproteinemia.

  1995cites this paper
• Lipid parameters including Lp(a) in hemodialysis patients.

  1994cites this paper
• Nutritional requirements of peritoneal dialysis patients

  1994cites this paper
• Cardiovascular risk factors and their management in patients on continuous ambulatory peritoneal dialysis.

  1994cites this paper
• Lipoprotein (a)

  1994cites this paper
• Apolipoprotein(a) phenotypes predict the risk for carotid atherosclerosis in patients with end-stage renal disease.

  1994cites this paper